MPM BIOIMPACT LLC
Filing Date
Global Rank
#1,534
/ 8,604
▲ 463
· as of Mar 2026
Top Industry
Biotechnology
94.5%
3Y Alpha vs SPY
+1.0%
Period ended 3 months ago
Filed May 15, 2026 · 54d
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+87.9%
SPY
+76.5%
Annualised alpha
+2.6%
Max drawdown
−46.1%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
41 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
8.4%
−1.0 pts
Top 5
31.6%
+0.2 pts
Top 10
49.0%
−2.5 pts
HHI
380
Diversified−26
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $1,294,902,829 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
20 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| DBVT | DBV Technologies S.A. | +4,216,536 | 5,213,361 | $108,907,111 | |
| EVMN | Evommune, Inc. | +1,342,841 | 1,455,863 | $33,470,290 | |
| ARQT | Arcutis Biotherapeutics, Inc. | +202,766 | 733,966 | $17,292,238 | |
| RLAY | Relay Therapeutics, Inc. | +127,135 | 2,359,586 | $23,477,880 | |
| XENE | Xenon Pharmaceuticals Inc. | +103,086 | 588,706 | $34,233,253 | |
| ABVX | Abivax S.A. | +50,952 | 107,268 | $11,944,291 | |
| TRVI | Trevi Therapeutics, Inc. | +11,343 | 3,298,430 | $39,350,269 | |
| EWTX | Edgewise Therapeutics, Inc. | +5,440 | 1,660,696 | $52,311,924 | |
| ORIC | Oric Pharmaceuticals, Inc. | +5,228 | 1,803,945 | $22,855,983 | |
| ENGN | enGene Therapeutics Inc. | +4,475 | 1,845,373 | $12,566,990 | |
| LQDA | Liquidia Corp | +4,289 | 1,405,158 | $53,030,662 | |
| GLUE | Monte Rosa Therapeutics, Inc. | +3,552 | 1,176,928 | $19,360,465 | |
| SNDX | Syndax Pharmaceuticals Inc | +3,031 | 1,340,733 | $31,319,522 | |
| AGIO | Agios Pharmaceuticals, Inc. | +2,888 | 1,306,261 | $44,190,809 | |
| DYN | Dyne Therapeutics, Inc. | +2,764 | 1,408,152 | $25,529,795 | |
| URGN | UroGen Pharma Ltd. | +2,425 | 943,803 | $16,969,577 | |
| RVMD | Revolution Medicines, Inc. | +1,104 | 506,776 | $49,283,966 | |
| TARS | Tarsus Pharmaceuticals, Inc. | +881 | 329,750 | $23,131,962 | |
| PVLA | Palvella Therapeutics, Inc. | +659 | 206,404 | $25,728,258 | |
| BLTE | Belite Bio, Inc | +285 | 88,045 | $14,037,894 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
8 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CRVS | Corvus Pharmaceuticals, Inc. | −1,068,796 | 1,674,875 | $24,503,421 | |
| HOWL | Werewolf Therapeutics, Inc. | −184,747 | 1,208,810 | $1,006,938 | |
| CLYM | Climb Bio, Inc. | −78,041 | 2,593,439 | $17,765,057 | |
| DRUG | Bright Minds Biosciences Inc. | −17,972 | 212,175 | $15,482,409 | |
| ALMS | Alumis Inc. | −15,463 | 2,386,529 | $52,575,233 | |
| QURE | uniQure N.V. | −12,397 | 1,369,231 | $22,386,926 | |
| STOK | Stoke Therapeutics, Inc. | −3,251 | 767,038 | $24,974,757 | |
| NTRA | Natera, Inc. | −477 | 93,074 | $18,613,869 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
11 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AKTS | Aktis Oncology, Inc. | 4,835,872 | $86,513,750 | |
| CORT | Corcept Therapeutics Inc | 985,700 | $39,733,567 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 423,982 | $35,580,569 | |
| MLTX | MoonLake Immunotherapeutics | 1,811,082 | $33,758,568 | |
| TVTX | Travere Therapeutics, Inc. | 1,133,365 | $33,672,274 | |
| CYTK | Cytokinetics Inc | 500,000 | $32,955,000 | |
| FBRX | Forte Biosciences, Inc. | 1,000,682 | $25,917,663 | |
| ZYME | Zymeworks Inc. | 565,249 | $14,153,834 | |
| VRDN | Viridian Therapeutics, Inc.DE | 649,873 | $12,711,515 | |
| ALLO | Allogene Therapeutics, Inc. | 2,242,933 | $5,472,756 | |
| ACRS | Aclaris Therapeutics, Inc. | 391,918 | $1,469,692 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
6 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| MDGL | Madrigal Pharmaceuticals, Inc. | 96,780 | $56,358,865 | |
| PTCT | Ptc Therapeutics, Inc. | 430,013 | $32,663,787 | |
| PTGX | Protagonist Therapeutics, Inc | 199,471 | $17,421,797 | |
| RCKT | Rocket Pharmaceuticals, Inc. | 1,586,076 | $5,567,126 | |
| MAZE | Maze Therapeutics, Inc. | 81,145 | $3,361,837 | |
| SRPT | Sarepta Therapeutics, Inc. | 70,000 | $1,506,400 | |
| No positions match the current search. | ||||
41 positions ·
$1,294,902,829 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| DBVT |
DBV Technologies S.A.
Healthcare
|
Reduced | 5,213,361 | $108,907,111 | 8.41% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
Held | 7,648,268 | $108,681,888 | 8.39% | |
| AKTS |
Aktis Oncology, Inc.
Healthcare
|
NEW | 4,835,872 | $86,513,750 | 6.68% | |
| LQDA |
Liquidia Corp
Healthcare
|
Added | 1,405,158 | $53,030,662 | 4.10% | |
| ALMS |
Alumis Inc.
Healthcare
|
Reduced | 2,386,529 | $52,575,233 | 4.06% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Added | 1,660,696 | $52,311,924 | 4.04% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 506,776 | $49,283,966 | 3.81% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
Added | 1,306,261 | $44,190,809 | 3.41% | |
| CORT |
Corcept Therapeutics Inc
Healthcare
|
NEW | 985,700 | $39,733,567 | 3.07% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Added | 3,298,430 | $39,350,269 | 3.04% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
NEW | 423,982 | $35,580,569 | 2.75% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Added | 588,706 | $34,233,253 | 2.64% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
NEW | 1,811,082 | $33,758,568 | 2.61% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
NEW | 1,133,365 | $33,672,274 | 2.60% | |
| EVMN |
Evommune, Inc.
Healthcare
|
Added | 1,455,863 | $33,470,290 | 2.58% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
NEW | 500,000 | $32,955,000 | 2.54% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Added | 1,340,733 | $31,319,522 | 2.42% | |
| CNTX |
Context Therapeutics Inc.
Healthcare
|
Reduced | 10,679,391 | $27,980,004 | 2.16% | |
| FBRX |
Forte Biosciences, Inc.
Healthcare
|
NEW | 1,000,682 | $25,917,663 | 2.00% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
Added | 206,404 | $25,728,258 | 1.99% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Added | 1,408,152 | $25,529,795 | 1.97% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
Reduced | 767,038 | $24,974,757 | 1.93% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
Healthcare
|
Reduced | 1,674,875 | $24,503,421 | 1.89% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
Added | 2,359,586 | $23,477,880 | 1.81% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Added | 329,750 | $23,131,962 | 1.79% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Added | 1,803,945 | $22,855,983 | 1.77% | |
| QURE |
uniQure N.V.
Healthcare
|
Reduced | 1,369,231 | $22,386,926 | 1.73% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
Added | 1,176,928 | $19,360,465 | 1.50% | |
| NTRA |
Natera, Inc.
Healthcare
|
Reduced | 93,074 | $18,613,869 | 1.44% | |
| CLYM |
Climb Bio, Inc.
Healthcare
|
Reduced | 2,593,439 | $17,765,057 | 1.37% | |
| ARQT |
Arcutis Biotherapeutics, Inc.
Healthcare
|
Added | 733,966 | $17,292,238 | 1.34% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
Added | 943,803 | $16,969,577 | 1.31% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
Reduced | 212,175 | $15,482,409 | 1.20% | |
| ZYME |
Zymeworks Inc.
Healthcare
|
NEW | 565,249 | $14,153,834 | 1.09% | |
| BLTE |
Belite Bio, Inc
Healthcare
|
Added | 88,045 | $14,037,894 | 1.08% | |
| VRDN |
Viridian Therapeutics, Inc.DE
Healthcare
|
NEW | 649,873 | $12,711,515 | 0.98% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
Added | 1,845,373 | $12,566,990 | 0.97% | |
| ABVX |
Abivax S.A.
Healthcare
|
Added | 107,268 | $11,944,291 | 0.92% | |
| ALLO |
Allogene Therapeutics, Inc.
Healthcare
|
NEW | 2,242,933 | $5,472,756 | 0.42% | |
| ACRS |
Aclaris Therapeutics, Inc.
Healthcare
|
NEW | 391,918 | $1,469,692 | 0.11% | |
| HOWL |
Werewolf Therapeutics, Inc.
Healthcare
|
Reduced | 1,208,810 | $1,006,938 | 0.08% |